After opioid-meltdown, Mallinckrodt gets ready for company restructuring

September 16, 2021

Morphic’s EMERALD-1 trial for ulcerative colitis disappoints

September 26, 2023

Theramex purchases Asieris’ innovative cervical lesion treatment for up to $250 million

October 10, 2026

Must Read

GSK’s Hepatitis B Drug Gets FDA Green Light

October 22, 2026

Real-Time Commercial Intelligence in Life Sciences

October 22, 2026

Top 10 AI Skills Every Life Sciences Leader Needs

October 22, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Argenx Scraps Phase III Sjögren Study Over Predicted Efficacy Failure

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

Disc Medicine’s Bitopertin Meets Phase 3 Goals in Rare Sunlight-Sensitivity Disorder

Vanda Puts Social Anxiety Program on Hold After Asset Fails Phase 3 Study

Tortugas Neuroscience Reports Positive Phase 2b Results for Schizophrenia Drug

BioNTech’s mRNA cancer vaccine fails phase 3 test

AstraZeneca Pens $1.5B Deal With Insitro Targeting Cardiometabolic Diseases

Merck to Acquire Silence Therapeutics for $1.3 Billion, Adding Experimental Blood Cancer Therapy

Roche Signs Huge Deal With Rona, Joins ALK7 Obesity Race

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Real-Time Commercial Intelligence in Life Sciences

Top 10 AI Skills Every Life Sciences Leader Needs

Digital Therapeutics 2.0: The Next Phase of Software-Based Treatment

Top 10 Advances in Protein Engineering

Tag: Isembyld FDA Approval

FDA Approves Scholar Rock’s Isembyld for Spinal Muscular Atrophy

Editor Picks

After opioid-meltdown, Mallinckrodt gets ready for company restructuring

Morphic’s EMERALD-1 trial for ulcerative colitis disappoints

Theramex purchases Asieris’ innovative cervical lesion treatment for up to $250 million

Must Read

GSK’s Hepatitis B Drug Gets FDA Green Light

Real-Time Commercial Intelligence in Life Sciences

Top 10 AI Skills Every Life Sciences Leader Needs

Hot Topics

About Us

Follow Us